Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Nasdaq    NDAQ


Real-time Estimate Quote. Real-time Estimate Cboe BZX - 10/22 02:27:44 pm
131.61 USD   -0.57%
10/21NEWS HIGHLIGHTS : Top Financial Services News of the Day
10/21NASDAQ : Q3 20 Earnings Presentation
10/21Nasdaq quarterly profit tops estimates as indexes shine
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Nasdaq Indexes Lead Way on Both Sides of Atlantic

share with twitter share with LinkedIn share with facebook
08/03/2020 | 05:45am EDT

By Ben Dummett

Nasdaq Inc. is cleaning up on both sides of the Atlantic.

In the U.S., the stock-exchange operator's Nasdaq indexes are the country's best-performing major stock benchmarks this year. In Europe, the Nasdaq-owned Copenhagen exchange's index is leading the charge.

Like its U.S. counterpart, Denmark's stock exchange is thriving in a coronavirus world. But the narrower base of big stocks behind the gain could make it a riskier bet.

The Copenhagen exchange's OMX Copenhagen 20 index is largely dominated by the health-care sector. High single- and double-digit gains in three constituents -- Novo Nordisk A/S, Genmab A/S and Coloplast A/S -- all of which are health-care stocks, have helped lift the benchmark more than 13% year to date. Meanwhile, Europe's other 18 country equity benchmarks are all trading lower.

That outperformance comes as Europe battles the coronavirus-induced recession, pushing investors into so-called growth and defensive sectors. Health-care stocks are often in that group because sick people can't do without drugs and treatment. Insulin maker Novo Nordisk and Coloplast, a supplier of continence care and other products, both reported higher sales for their latest quarters, citing supply stockpiling as a reason.

Still, the concentration leaves the market index at risk of an abrupt downturn if any of these health-care companies suffer a surprise setback. Novo Nordisk, for example, carries an index weighting of 33%. That compares with a combined weighting of about 40% for the five biggest stocks in the Nasdaq Composite Index -- Apple Inc., Microsoft Corp., Amazon.com Inc., Facebook Inc. and Alphabet Inc. -- big drivers behind its outperformance in 2020. Together with Genmab, a Danish biotech company, and Coloplast, the three health-care stocks' total weighing is close to 50%.

"There is some stock-specific risk that you really need to look out for, " said Kenneth Lamont, a research analyst at Morningstar.

In 2018, Novo Nordisk fell 7.3% in one session on disappointing earnings. Danske Bank at the time blamed the sell off for a big part of a 3% drop in OMXC20 and its underperformance against rival markets that day.

The Xact OMXC25 and iShares MSCI Denmark ETF are exchange-traded funds that allow investors to bet on the Copenhagen exchange. While each ETF tracks more companies than included in the OMXC20, health-care weightings remain the biggest for each.

The OMXC25 trades at around 29 times projected earnings of the constituent companies, compared with a 10-year average of 18.6 times, according to Danske Bank, suggesting valuation is another potential risk. The growth outlook of companies such as Genmab helps to explain the richer valuation. In June, the biotech company struck a $750 million deal with AbbVie Inc. to develop cancer treatments, and the stock is up about 15% since then.

Still, Danske Bank recommends underweighting the Danish market. Growth stocks like health care are expensive, and more cyclical stocks should perform relatively better over the next three to nine months as the economy recovers, said Chief Equity Strategist Mattias Sundling.

Germany's DAX stock index, which has big weightings in industrials and autos, has gained more than 45% from its low in March, outperforming the OMXC20's 37% gain over the same period, in a possible sign of support for that view.

-- To receive our Markets newsletter every morning in your inbox, click here.

Write to Ben Dummett at ben.dummett@wsj.com


Stocks mentioned in the article
ChangeLast1st jan.
ABBVIE INC. 2.18% 84.795 Delayed Quote.-6.38%
ALPHABET INC. 1.47% 1608.39 Delayed Quote.18.41%
APPLE INC. -1.29% 115.5184 Delayed Quote.59.20%
COLOPLAST A/S -0.47% 969 Delayed Quote.17.81%
DANSKE BANK A/S -0.11% 91.72 Delayed Quote.-14.82%
DAX -0.12% 12543.06 Delayed Quote.-5.22%
DJ INDUSTRIAL 0.51% 28367.6 Delayed Quote.-1.15%
FACEBOOK INC -0.24% 278.2099 Delayed Quote.35.80%
GENMAB A/S -0.90% 2208 Delayed Quote.50.39%
MICROSOFT CORPORATION 0.03% 214.91 Delayed Quote.36.11%
MORNINGSTAR, INC. -0.09% 184.14 Delayed Quote.21.79%
NASDAQ -0.48% 131.805 Delayed Quote.23.59%
NASDAQ 100 -0.02% 11667.024311 Delayed Quote.33.72%
NASDAQ COMP. 0.16% 11506.261449 Delayed Quote.28.00%
NOVO NORDISK A/S -0.50% 444.1 Delayed Quote.15.44%
OMX COPENHAGEN 20 -0.85% 1375.53182 Delayed Quote.22.14%
S&P 500 0.48% 3453.27 Delayed Quote.6.57%
share with twitter share with LinkedIn share with facebook
All news about NASDAQ
10/21NEWS HIGHLIGHTS : Top Financial Services News of the Day
10/21NASDAQ : Q3 20 Earnings Presentation
10/21Nasdaq quarterly profit tops estimates as indexes shine
10/21NASDAQ, INC. : Results of Operations and Financial Condition, Regulation FD Disc..
10/21NASDAQ : Announces Retirement of Chief Financial Officer Michael Ptasznik
10/21Nasdaq Announces Retirement of Chief Financial Officer Michael Ptasznik
10/21NASDAQ : Announces Quarterly Dividend of $0.49 Per Share
10/21NASDAQ : Reports Third Quarter 2020 Results; Delivers Broad-Based 13% Revenue Gr..
10/21Nasdaq Announces Quarterly Dividend of $0.49 Per Share
10/21Nasdaq Reports Third Quarter 2020 Results; Delivers Broad-Based 13% Revenue G..
More news
Financials (USD)
Sales 2020 2 829 M - -
Net income 2020 971 M - -
Net Debt 2020 2 122 M - -
P/E ratio 2020 23,5x
Yield 2020 1,47%
Capitalization 21 743 M 21 743 M -
EV / Sales 2020 8,44x
EV / Sales 2021 8,21x
Nbr of Employees 4 670
Free-Float 67,0%
Duration : Period :
Nasdaq Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NASDAQ
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 137,53 $
Last Close Price 132,37 $
Spread / Highest target 14,8%
Spread / Average Target 3,90%
Spread / Lowest Target -28,2%
EPS Revisions
Adena T. Friedman President, Chief Executive Officer, COO & Director
Michael R. Splinter Chairman
Michael Ptasznik Chief Financial Officer & EVP-Corporate Strategy
Bradley J. Peterson Chief Information Officer & Executive VP
Lars Rune Wedenborn Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
NASDAQ23.59%21 743
B3 S.A. - BRASIL, BOLSA, BALCÃO33.51%21 216